# Effect of Empagliflozin on Ventricular Repolarization.

> **NCT04117763** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 90 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Coronary Heart Disease
- Arrythmia, Cardiac

## Interventions

- **DRUG:** Empagliflozin 25 MG

## Key facts

- **NCT ID:** NCT04117763
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-04
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117763, "Effect of Empagliflozin on Ventricular Repolarization.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04117763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*